Interleukin 10 (IL-10) inhibition of primary human prostate cell- induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 189-196

  Stearns, Mark E ^a   Rhim, Johng ^b   Wang, Min ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; ARTICLE; COCULTURE; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; PROSTATE; PROTEIN SECRETION; WART VIRUS;

ANTIBODIES; BONE MARROW CELLS; COCULTURE TECHNIQUES; COLLAGENASES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELATINASES; HUMANS; INTERLEUKIN-10; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED;

EID: 0032953206     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg., 175: 409-416, 1972.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat. Med., 27: 27-29, 1995.
3. Weidner, N. Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
4. Folkman, J. Tumor angiogenesis. In: J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 206-232. Philadelphia: W. B. Saunders, 1995.
5. Peehl, D. M. Culture of human prostatic epithelial cells. In: I. A. Freshney (ed.), Culture of Epithelial Cells, pp. 159-180. New York: Wiley-Liss, Inc., 1992.
6. Wang, M., Fudge, K., Rhim, J. S., and Stearns, M. E. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines. Oncol. Res., 8: 303-315, 1996.
7. Rhim, J. S., Park, J. B., and Gilbert, J. Neoplastic transformation of human keratinocytes of polybrene induced DNA mediated transfer of an activated oncogene. Oncogene, 4: 1403-1409, 1989.
8. Ariga, H., and Sugano, S. Initiation of simian virus 40 DNA replication in vitro. J. Virol., 48: 481-491, 1983.
9. Voyta, J. C., Via, D. P., Butterfield, C. E., and Zetter, B. R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol., 99: 2034-2040, 1984.
10. Pienta, K. J., and Lehr, J. E. Isolation of a human bone marrow endothelial cell line which demonstrates preferential adhesion of prostate cancer cells. J. Natl. Cancer Inst. (Bethesda), in press, 1999.
11. Qian, X., Wang, T. N., Rothman, V. L., Nicosia, R. F., and Tuszynski, G. P. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp. Cell Res., 255; 403-412, 1997.
12. Nicosia, R. F., Tchao, R., and Leighton J. Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res., 43: 2159-2166, 1983.
13. Nicosia, R. F., and Ottinetti, A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest., 63: 115-122, 1990.
14. Nicosia, R. F., and Tuszynski, G. P. Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol., 124: 183-193, 1994.
15. Stearns, M. E., Wang, M., and Fudge, K. Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity. Cancer Res., 53: 3073-3077, 1993.
16. Stearns, M. E., and Wang, M. Immunoassays of the metalloproteinase (MMP-2, 9) and tissue inhibitor of metalloproteinase (TIMP-1, 2) levels in non-invasive and metastatic PC-3 clones. Effects of Taxol. Oncol. Res., 6: 195-202, 1996.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Stearns, M., Wang, M., and Stearns, M. E. Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol. Res. 7: 173-181, 1995.
19. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., and Dayer, J-M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest., 96: 2304-2310, 1995.
20. Sato, T., McCue, P., Masuoka, K., Salwen, S., Lattime, E. D., Mastrangelo, M. J., and Berd, D. Interleukin 10 production by human melanoma. Clin. Cancer Res., 2: 1383-1390, 1996.
21. Huang, S., Xie, K., Bucana, C. D., Ullrich, S. E., and Bar-Eli, M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res., 2: 1969-1979, 1996.
22. Kundu, N., Beaty, T. L., Jackson, M. J., and Fulton, A. M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst. (Bethesda), 88: 536-541, 1996.
23. Richiter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamantstein, T., and Blankenstein, T. Interleukin 10 transfected into Chinese harnster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res., 53: 4134-4137, 1993.
24. Stearns, M. E., and Wang, M. Antimetastatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones. Orthotopic growth in SCID mice. Clin. Cancer Res., 4: 2257-2263, 1998.